TABLE 2. Association Between Depression and Heart Rate Variability Indices During 24 Hour and Daytime Observations.
24 Hour HRV | Daytime HRV | |||||||
---|---|---|---|---|---|---|---|---|
Not Depressed (CES-D <8) n = 776 |
Depressed (CES-D ≥8) n = 131 |
p Unadjusted | p Adjusteda | Not Depressed (CES-D <8) n = 776 |
Depressed (CES-D ≥8) n = 131 |
p Value Unadjusted | p Adjusteda | |
VLF-HRV | 6.92 ± 0.64 | 6.79 ± 0.62 | .036 | .13 | 6.72 ± 0.63 | 6.61 ± 0.63 | .059 | .14 |
LF-HRV | 5.87 ± 0.83 | 5.78 ± 0.82 | .26 | .53 | 0.57 ± 0.78 | 5.47 ± 0.79 | .17 | .25 |
HF-HRV | 4.81 ± 1.04 | 4.74 ± 1.04 | .49 | .61 | 4.42 ± 1.03 | 4.35 ± 0.96 | .49 | .64 |
Total power | 9.55 ± 0.58 | 9.51 ± 0.52 | .46 | .70 | 9.09 ± 0.60 | 9.10 ± 0.57 | .94 | .57 |
SDNN | 124.7 ± 35.5 | 121.9 ± 31.3 | .41 | .69 | 98.3 ± 30.3 | 98.3 ± 29.0 | .98 | .55 |
RMSSD | 27.5 ± 20.8 | 26.8 ± 21.9 | .72 | .90 | 23.9 ± 18.4 | 22.4 ± 13.8 | .39 | .56 |
PNN50 | 6.01 ± 8.84 | 5.27 ± 7.58 | .37 | .50 | 4.81 ± 8.71 | 3.98 ± 6.15 | .29 | .42 |
DFA1 <1.0 | 247 (31.8%) | 43 (32.8%) | .82 | .98 | 233 (30.0%) | 53 (40.5%) | .017 | .017 |
HRT onset >0 | 109 (14.0%) | 17 (13.0%) | .74 | .86 | 40 (5.2%) | 4 (3.1%) | .30 | .24 |
HRT slope | 130 (17.0%) | 24 (18.5%) | .69 | .58 | 123 (15.9%) | 20 (15.3%) | .98 | .92 |
Heart rate | 73.8 ± 9.0 | 73.9 ± 7.4 | .92 | .66 | 79.2 ± 10.2 | 79.4 ± 8.4 | .91 | .70 |
HRV = heart rate variability; CES-D = Centers for Epidemiological Studies Depression scale; VLF = very low frequency; LF = low frequency; SDNN = standard deviation of the NN intervals; RMMSD = square root of mean square successive difference of NN intervals; PNN50 = percent of successive NN interval differences >50 ms; DFA1 = detrended fluctuation analysis for the short-term fractal scaling exponent; HRT = heart rate turbulence.
Units: VLF, LF, HF and total power HRV in ln ms2; SDNN and RMSSD in ms; and PNN50 in %; HRT onset >0%.
HRT slope, <3 ms/beat; heart rate, beats/min.
Adjusted for age, sex, systolic blood pressure, diabetes, body mass index, physical activity (kcal/wk), and use of β-adrenergic blocking agents.
Data are presented as mean ± standard deviation or N and (%).